Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
AD-Anires Acid is a veterinary feed additive developed by ADBiotech, a South Korean biotechnology company specializing in animal health and antibiotic alternatives. Marketed for use in livestock and fisheries, it belongs to a category of acidifiers designed to optimize the gastrointestinal environment. By lowering the pH within the digestive tract, AD-Anires Acid helps to suppress the growth of acid-sensitive pathogenic bacteria such as *Salmonella* and *Escherichia coli*, while simultaneously promoting the activity of digestive enzymes and the growth of beneficial microflora. This mechanism supports improved feed conversion ratios, enhanced nutrient absorption, and overall animal growth performance, serving as a functional alternative to antibiotic growth promoters in agricultural and aquaculture settings.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on AD-Anires Acid.